ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 94 | ESPE2021 | Next issue

59th Annual ESPE (ESPE 2021 Online)

Online,
22 Sept 2021 - 26 Sept 2021

Card image cap
The 59th ESPE Annual Meeting will now be held online in September 2021.

ePoster Category 2

Growth hormone and IGFs

Previous section
Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Table of contents
Next section
Growth and syndromes (to include Turner syndrome)

hrp0094p2-246 | Growth hormone and IGFs

Massive Open Online Learning – accelerating knowledge in digital health in the management of children with growth disorders

hrp0094p2-247 | Growth hormone and IGFs

A girl with concurrent congenital adrenal hyperplasia, isolated growth hormone deficiency type II (IGHD II) and a new mutation in the GH 1 gene – an extremely unusual case

hrp0094p2-248 | Growth hormone and IGFs

Reduction in pappalysin and stanniocalcin levels explain the decrease in IGF-I bioavailability in anorexia nervosa

hrp0094p2-249 | Growth hormone and IGFs

Predictors of short stature in premature infants born small for gestational age

hrp0094p2-250 | Growth hormone and IGFs

Patterns of suboptimal adherence to growth hormone treatment in children living in Italy

hrp0094p2-251 | Growth hormone and IGFs

Screening of celiac disease among children with growth hormone deficiency and idiopathic short stature

hrp0094p2-252 | Growth hormone and IGFs

Pappalysins and stanniocalcins in prenatal and postnatal life

hrp0094p2-253 | Growth hormone and IGFs

GROWPATI Study: Growth and puberty description pattern in a well-characterized cohort of patients with growth retardation due to severe primary IGF1 deficiency

hrp0094p2-254 | Growth hormone and IGFs

Clinic, laboratory and prognostic findings of patients who are diagnosed by Kowarski syndrome (biologically inactive growth hormone)

hrp0094p2-255 | Growth hormone and IGFs

Prevalence of insulin-like growth factor 1 (IGF1) deficiency in prepubertal children with isolated short stature (ISS) and their response to GH therapy.

hrp0094p2-256 | Growth hormone and IGFs

Thyroid function (TF) in short children with idiopathic short stature (ISS) treated with growth hormone (GH)versus those not treated; a controlled study.

hrp0094p2-257 | Growth hormone and IGFs

Investigating the impact of the TuiTek patient support programme, designed to support caregivers of children prescribed recombinant human growth hormone treatment for growth hormone deficiency in Taiwan: A pilot study

hrp0094p2-258 | Growth hormone and IGFs

Incidence of ALS deficiency in patients with growth hormone deficiency at tertiary pediatric endocrinology center

hrp0094p2-259 | Growth hormone and IGFs

Presentation of IGF-1/IGFBP-3 molar ratio as an effective monitoring index during treatment of growth hormone deficient patients

hrp0094p2-260 | Growth hormone and IGFs

Current growth hormone therapy practices in Belgium for the treatment of short children born small for gestational age

hrp0094p2-261 | Growth hormone and IGFs

Increased height and IGF1 serum levels in children with non-neurofibromatosis type 1 gliomas

hrp0094p2-262 | Growth hormone and IGFs

A Survey on Clinician Perceptions of Long-Acting Growth Hormone Analogs

hrp0094p2-263 | Growth hormone and IGFs

Pituitary gland volume measured by Magnetic Resonance Imaging as diagnostic predictor of persistent Childhood-onset growth hormone deficiency

hrp0094p2-264 | Growth hormone and IGFs

Growth hormone (GH) treatment of children with idiopathic short children (ISS) with normal insulin-like growth factor-1 (IGF-1) versus those with low IGF-I at diagnosis.

hrp0094p2-265 | Growth hormone and IGFs

Growth response to growth hormone therapy in growth hormone deficient (GHD) children in relation to the distance between their height SDS (HtSDS) and their mid-parental height.

hrp0094p2-266 | Growth hormone and IGFs

Linear growth and response to GH therapy in children with short stature with normal Growth hormone secretion: Comparison between children with delayed versus no delay in the bone age at diagnosis.

hrp0094p2-267 | Growth hormone and IGFs

Linear growth and response to GH therapy in children with GHD with normal IGF-I versus those with normal GH secretion associated with low IGFI at presentation.

hrp0094p2-268 | Growth hormone and IGFs

Growth response to growth hormone therapy in short children in relation to their distance from mid-parental heights (MPHt).

hrp0094p2-269 | Growth hormone and IGFs

Immunogenicity of recombinant growth hormone therapy in the children with short stature and consequences on growth-promoting effect

hrp0094p2-270 | Growth hormone and IGFs

Unified training materials to improve adherence to GH-treatment

hrp0094p2-271 | Growth hormone and IGFs

Linear growth of prepubertal children born small for gestational age on growth hormone therapy for 3 years

hrp0094p2-272 | Growth hormone and IGFs

Evaluation of the clinical and laboratory parameters and final adult height in patients treated with recombinant human growth hormone.

hrp0094p2-273 | Growth hormone and IGFs

The results of treatment with growth hormone in a patient with growth hormone deficiency and type 1 diabetes

hrp0094p2-274 | Growth hormone and IGFs

Aetiology and different clinical conditions of GHD in children in a region of North Africa

hrp0094p2-275 | Growth hormone and IGFs

Growth hormone therapy in short stature: The variability of responses to treatment after one year. About 41 cases

hrp0094p2-276 | Growth hormone and IGFs

Growth Hormone Resistance; The Iraqi experience

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more